Christopher Dinsmore - Net Worth and Insider Trading

Christopher Dinsmore Net Worth

The estimated net worth of Christopher Dinsmore is at least $271,408 dollars as of 2024-06-18. Christopher Dinsmore is the Chief Scientific Officer of Kronos Bio Inc and owns about 260,969 shares of Kronos Bio Inc (KRON) stock worth over $271,408. Details can be seen in Christopher Dinsmore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher Dinsmore has not made any transactions after 2024-01-04 and currently still holds the listed stock(s).

Transaction Summary of Christopher Dinsmore

To

Christopher Dinsmore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Dinsmore owns 1 companies in total, including Kronos Bio Inc (KRON) .

Click here to see the complete history of Christopher Dinsmore’s form 4 insider trades.

Insider Ownership Summary of Christopher Dinsmore

Ticker Comapny Transaction Date Type of Owner
KRON Kronos Bio Inc 2024-01-04 Chief Scientific Officer

Christopher Dinsmore Latest Holdings Summary

Christopher Dinsmore currently owns a total of 1 stock. Christopher Dinsmore owns 260,969 shares of Kronos Bio Inc (KRON) as of January 4, 2024, with a value of $271,408.

Latest Holdings of Christopher Dinsmore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KRON Kronos Bio Inc 2024-01-04 260,969 1.04 271,408

Holding Weightings of Christopher Dinsmore


Christopher Dinsmore Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Dinsmore has made a total of 10 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Kronos Bio Inc is the sale of 7,366 shares on January 4, 2024, which brought Christopher Dinsmore around $8,692.

Insider Trading History of Christopher Dinsmore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Dinsmore Trading Performance

GuruFocus tracks the stock performance after each of Christopher Dinsmore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Dinsmore is 1.24%. GuruFocus also compares Christopher Dinsmore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Dinsmore within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher Dinsmore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher Dinsmore

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -14.43 LIMIT LIMIT LIMIT LIMIT LIMIT

Christopher Dinsmore Ownership Network

Ownership Network List of Christopher Dinsmore

No Data

Ownership Network Relation of Christopher Dinsmore

Insider Network Chart

Christopher Dinsmore Owned Company Details

What does Kronos Bio Inc do?

Who are the key executives at Kronos Bio Inc?

Christopher Dinsmore is the Chief Scientific Officer of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Medical Officer & VP Jorge Dimartino .

Kronos Bio Inc (KRON) Insider Trades Summary

Over the past 18 months, Christopher Dinsmore made 4 insider transaction in Kronos Bio Inc (KRON) with a net sale of 30,323. Other recent insider transactions involving Kronos Bio Inc (KRON) include a net sale of 50,347 shares made by Jorge Dimartino , a net purchase of 4,736,178 shares made by Norbert W Bischofberger , and a net sale of 18,643 shares made by Yasir B. Al-wakeel .

In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 3,005,122 shares, with a net purchase of 3,005,122 shares. During the past 18 months, 141,498 shares of Kronos Bio Inc (KRON) were sold and 4,736,178 shares were bought by its insiders, resulting in a net purchase of 4,594,680 shares.

Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kronos Bio Inc Insider Transactions

No Available Data

Christopher Dinsmore Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Dinsmore. You might contact Christopher Dinsmore via mailing address: C/o Kronos Bio, Inc., 1300 El Camino Real, Ste. 300, San Mateo Ca 94402.

Discussions on Christopher Dinsmore

No discussions yet.